Osteopontin: Role in cell signaling and cancer progression

Trends in Cell Biology

Volumn 16, Issue 2, 2006, Pages 79-87

  Rangaswami, Hema ^a   Bulbule, Anuradha ^a   Kundu, Gopal C ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; HERMES ANTIGEN; INTEGRIN; MATRIX METALLOPROTEINASE; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; SCLEROPROTEIN; TUMOR MARKER;

AMINO TERMINAL SEQUENCE; ATHEROSCLEROSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COLON ADENOCARCINOMA; DEGRADATION KINETICS; DNA MICROARRAY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN VERSUS NONHUMAN DATA; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; MELANOMA; MOLECULAR DYNAMICS; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE PROGRESSION; HUMANS; NEOPLASMS; OSTEOPONTIN; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION;

EID: 32644467590     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2005.12.005     Document Type: Review

References (80)

1. B. Boilly FGF signals for cell proliferation and migration through different pathways Cytokine Growth Factor Rev. 11 2000 295 302
2. R.L. Elliott, and G.C. Blobe Role of transforming growth factor beta in human cancer J. Clin. Oncol. 23 2005 2078 2093
3. G.F. Weber The metastatic gene osteopontin: a candidate target for cancer therapy Biochim. Biophys. Acta 1552 2001 61 85
4. S.R. Rittling, and A.F. Chambers Role of osteopontin in tumor progression Br. J. Cancer 90 2004 1877 1881
5. H.A. Gardner Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts Oncogene 9 1994 2321 2326
6. D.T. Denhardt Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J. Clin. Invest. 107 2001 1055 1061
7. D. Panda Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty Proc. Natl. Acad. Sci. U. S. A. 94 1997 9308 9313
8. A. Junaid, and F.M. Amara Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI 3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells Histopathology 44 2004 136 146
9. Y. Ohyama Osteopontin-deficiency suppresses growth of B16 melanoma cells implanted in bone and osteoclastogenesis in co-cultures J. Bone Miner. Res. 19 2004 1706 1711
10. C.W. Prince Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone J. Biol. Chem. 262 1987 2900 2907
11. D.R. Senger Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain Mol. Biol. Cell 5 1994 565 574
12. 32P-labeled osteopontin from cultured chicken osteoblasts J. Biol. Chem. 272 1997 13966 13973
13. C.W. Prince Osteopontin, a substrate for transglutaminase and factor XIII activity Biochem. Biophys. Res. Commun. 177 1991 1205 1210
14. R. Agnihotri Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin) J. Biol. Chem. 276 2001 28261 28267
15. Y. Higashibata Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice J. Bone Miner. Res. 19 2004 78 88
16. F. Takahashi Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome Lung 182 2004 173 185
17. S. Kon Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms J. Cell. Biochem. 77 2000 487 498
18. H.C. Crawford Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo Cancer Res. 58 1998 5206 5215
19. L.W. Fisher, and N.S. Fedarko Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins Connect. Tissue Res. 44 2003 33 40
20. A. Karadag Bone sialoprotein, matrix metalloproteinase 2, and alpha(v) beta3 integrin in osteotropic cancer cell invasion J. Natl. Cancer Inst. 96 2004 956 965
21. N.S. Fedarko Three small integrin binding ligand N-linked glycoproteins (SIBLINGS) bind and activate specific matrix metalloproteinases FASEB J. 18 2004 734 736
22. N.S. Fedarko Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer Clin. Cancer Res. 7 2001 4060 4066
23. M. Ishijima Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin J. Exp. Med. 193 2001 399 404
24. M.A. Chellaiah Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression Mol. Biol. Cell 14 2003 173 189
25. S.A. Shapses Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency Calcif. Tissue Int. 73 2003 86 92
26. A. Strom Altered vascular remodeling in osteopontin-deficient atherosclerotic mice J. Vasc. Res. 41 2004 314 322
27. G. Li Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro Circulation 106 2002 854 859
28. R. Ohri Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin Calcif. Tissue Int. 76 2005 307 315
29. C.M. Giachelli Regulation of vascular calcification: roles of phosphate and osteopontin Circ. Res. 96 2005 717 722
30. H. Diao Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases Immunity 21 2004 539 550
31. A.C. Renkl Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype Blood 106 2005 946 955
32. S. Ashkar Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
33. J. Iizuka Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies Lab. Invest. 78 1998 1523 1533
34. E.A. Clark, and J.S. Brugge Integrins and signal transduction pathways: the road taken Science 268 1995 233 239
35. J.D. Hood, and D. Cheresh Role of integrins in cell invasion and migration Nat. Rev. Cancer 2 2002 91 100
36. K.A. Furger Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin Mol. Cancer Res. 1 2003 810 819
37. Y. Yokosaki The integrin alpha 9 beta 1 binds to a novel recognition sequence SVVYGLR in the thrombin cleaved amino terminal fragment of osteopontin J. Biol. Chem. 274 1999 36328 36334
38. S. Barry Analysis of the alpha 4 beta 1 integrin-osteopontin interaction Exp. Cell Res. 258 2000 342 351
39. Y.U. Katagiri CD44 variants but not CD44s cooperate with beta 1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine- aspartic acid, thereby stimulating cell motility and chemotaxis Cancer Res. 59 1999 219 226
40. H.R. Kim Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44 Cancer Res. 64 2004 4569 4576
41. T. Hidemi Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12 Oncogene 24 2005 489 501
42. A. Krettek Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells Am. J. Pathol. 165 2004 1571 1581
43. Y.H. Lin, and H.F. Yang-Yen The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway J. Biol. Chem. 276 2001 46024 46030
44. H.S. Wang CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4 beta1) Exp. Cell Res. 304 2005 116 126
45. O. Alper, and E.T. Bowden Novel insights into c-Src Curr. Pharm. Des. 11 2005 1119 1130
46. T. Volberg pp60 (c-Src) and related tyrosine kinases: a role in the assembly and reorganization of matrix adhesion J. Cell Sci. 114 2001 2279 2289
47. L. Moro Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130 Cas and leads to phosphorylation of specific EGF receptor tyrosines J. Biol. Chem. 277 2002 9405 9414
48. R. Das Osteopontin induces AP-1 mediated secretion of urokinase type plasminogen activator through c-Src dependent epidermal growth factor receptor transactivation in breast cancer cells J. Biol. Chem. 279 2004 11051 11064
49. A.B. Tuck Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways Oncogene 22 2003 1198 1205
50. Y. Yarden The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities Eur. J. Cancer 37 Suppl. 4 2001 S3 S8
51. N.E. Hynes, and H.A. Lane ERB B receptors and cancer: the complexity of targeted inhibitors Nat. Rev. Cancer 5 2005 341 354
52. R. Das Osteopontin stimulates cell motility and nuclear factor-κB mediated secretion of urokinase type plasminogen activator through phosphotidylinositol 3-kinase/Akt signaling pathways in breast cancer cells J. Biol. Chem. 278 2003 28593 28606
53. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signaling pathway in human malignancy Cell. Signal. 14 2002 381 395
54. J.A. Fresno Vara PI 3K/Akt signaling pathway and cancer Cancer Treat. Rev. 30 2004 193 204
55. T. Sugatani PTEN regulates RANKL- and OPN-stimulated signal transduction during osteoclast differentiation and cell motility J. Biol. Chem. 278 2003 5001 5008
56. N.L. Malinin MAP3K-related kinase involved in NF kappa B induction by TNF, CD95 and IL-1 Nature 385 1997 540 544
57. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nat. Cell Biol. 4 2002 E131 E136
58. H. Rangaswami Nuclear factor inducing kinase plays a crucial role in osteopontin induced MAPK/IκBα kinase dependent nuclear factor- κB mediated promatrix metalloproteinase-9 activation J. Biol. Chem. 279 2004 38921 38935
59. H. Rangaswami JNK1 differentially regulates osteopontin induced nuclear factor inducing kinase/MEKK1 dependent activating protein-1-mediated promatrix metalloproteinase-9 activation J. Biol. Chem. 280 2005 19381 19392
60. I. Stamenkovic Extracellular matrix remodelling: the role of matrix metalloproteinases J. Pathol. 200 2003 448 464
61. J. Romer The urokinase receptor as a potential target in cancer therapy Curr. Pharm. Des. 10 2004 2359 2376
62. A. Teti Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent Int. J. Cancer 77 1998 82 93
63. Q. Ding Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin Cancer Res. 62 2002 5336 5343
64. S. Philip, and G.C. Kundu Osteopontin induces nuclear factor-κB mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways and curcumin (diferulolylmethane) downregulates these pathways J. Biol. Chem. 278 2003 14487 14497
65. C. Haqq The gene expression signatures of melanoma progression Proc. Natl. Acad. Sci. U. S. A. 102 2005 6092 6097
66. P.Y. Wai, and P.C. Kuo The role of osteopontin in tumor metastasis J. Surg. Res. 121 2004 228 241
67. Y. Wu Osteopontin is required for full expression of the transformed phenotype by the ras oncogene Br. J. Cancer 83 2000 156 163
68. P.Y. Wai Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis Carcinogenesis 26 2005 741 751
69. D. Denhardt Osteopontin expression correlates with melanoma invasion J. Invest. Dermatol. 124 2005 16 18
70. E. Geissinger Autocrine stimulation of osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen Cancer Res. 62 2002 4820 4828
71. N.S. Fedarko Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack J. Biol. Chem. 275 2000 16666 16672
72. S.A. Khan Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors J. Cell. Biochem. 85 2002 728 736
73. R. Zohar Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway Am. J. Physiol. Heart Circ. Physiol. 287 2004 H1730 H1739
74. Z. Xie Osteopontin inhibits interleukin-1 beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta J. Biol. Chem. 278 2003 48546 48552
75. D.S. Bautista Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin J. Biol. Chem. 269 1994 23280 23285
76. D.Q. Zheng Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation J. Biol. Chem. 275 2000 24565 24574
77. L.M. Bafetti Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells J. Biol. Chem. 273 1998 143 149
78. K.J. Bayless Isolation and biological properties of osteopontin from bovine milk Protein Expr. Purif. 9 1997 309 314
79. S. Philip Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type-1 matrix metalloproteinase in murine melanoma cells J. Biol. Chem. 276 2001 44926 44935
80. S.K. Nilsson Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells Blood 106 2005 1232 1239